The cost of GLP-1 medications to group health plans continues to increase rapidly as FDA approval expands and the percentage of participants and beneficiaries taking GLP-1 medications rises. This ...
Alternative prescription drug access models—including direct-to-employer (DTE) and direct-to-consumer (DTC)—are gaining traction as employers reassess traditional pharmacy benefit manager (PBM)-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results